Sanofi buys hepatitis B vaccine maker Dynavax for $2.2B; gets CRL for MS drug

Sanofi is to supplement its vaccine offering with the acquisition of Dynavax Technologies for $2.2 billion in cash, the companies said Wednesday. The deal is the French drugmaker’s largest since it ...